A specific molar ratio of stabilizer to protein is required for storage stability of a lyophilized monoclonal antibody.
暂无分享,去创建一个
J L Cleland | Chung C. Hsu | J. Carpenter | J. Cleland | J F Carpenter | J Yang | X. Lam | X Lam | B Kendrick | T H Yang | D Overcashier | D Brooks | C Hsu | C. Hsu | J. Yang | D. Brooks | B. Kendrick | T. Yang | D. Overcashier | J. Yang | T. H. Yang | T. H. Yang | Tzung‐Horng Yang
[1] J. Carpenter,et al. Application of infrared spectroscopy to development of stable lyophilized protein formulations. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[2] M. Manning,et al. Effect of Tween 20 on freeze-thawing- and agitation-induced aggregation of recombinant human factor XIII. , 1998, Journal of pharmaceutical sciences.
[3] T. Arakawa,et al. Dehydration-induced conformational transitions in proteins and their inhibition by stabilizers. , 1993, Biophysical journal.
[4] B. Kabakoff,et al. Identification of multiple sources of charge heterogeneity in a recombinant antibody. , 2001, Journal of chromatography. B, Biomedical sciences and applications.
[5] K. Nielsen. Stability of freeze dried horseradish peroxidase conjugated monoclonal antibodies used in diagnostic serology. , 1995, Journal of immunoassay.
[6] G. Amidon,et al. Protein denaturation during freezing and thawing in phosphate buffer systems: monomeric and tetrameric beta-galactosidase. , 2000, Archives of biochemistry and biophysics.
[7] K. Middleton,et al. Optimization of storage stability of lyophilized actin using combinations of disaccharides and dextran. , 2000, Journal of pharmaceutical sciences.
[8] R. Langer,et al. Formulation and Delivery of Proteins and Peptides. Design and Development Strategies. , 1995 .
[9] H Leuenberger,et al. Formulations of sugars with amino acids or mannitol--influence of concentration ratio on the properties of the freeze-concentrate and the lyophilizate. , 1998, Pharmaceutical development and technology.
[10] J L Cleland,et al. The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation. , 1993, Critical reviews in therapeutic drug carrier systems.
[11] S. Yoshioka,et al. Effect of mannitol crystallinity on the stabilization of enzymes during freeze-drying. , 1994, Chemical & pharmaceutical bulletin.
[12] J L Cleland,et al. Antioxidants for prevention of methionine oxidation in recombinant monoclonal antibody HER2. , 1997, Journal of pharmaceutical sciences.
[13] D. Marshak,et al. TECHNIQUES IN PROTEIN CHEMISTRY VII , 1996 .
[14] R. Suryanarayanan,et al. Characterization of phase transitions during freeze-drying by in situ X-ray powder diffractometry. , 1998, Pharmaceutical development and technology.
[15] R. Artico,et al. Use of subambient differential scanning calorimetry to monitor the frozen-state behavior of blends of excipients for freeze-drying. , 1997, PDA journal of pharmaceutical science and technology.
[16] J. Carpenter,et al. Protein formulation and lyophilization cycle design: prevention of damage due to freeze-concentration induced phase separation. , 1999, Biotechnology and bioengineering.
[17] S J Prestrelski,et al. Separation of freezing- and drying-induced denaturation of lyophilized proteins using stress-specific stabilization. I. Enzyme activity and calorimetric studies. , 1993, Archives of biochemistry and biophysics.
[18] Reed J. Harris,et al. The application of tert-butylhydroperoxide oxidation to study sites of potential methionine oxidation in a recombinant antibody , 1996 .
[19] H Leuenberger,et al. Effects of formulation and process variables on the aggregation of freeze-dried interleukin-6 (IL-6) after lyophilization and on storage. , 1998, Pharmaceutical development and technology.
[20] L. Presta,et al. Humanization of an anti-p185HER2 antibody for human cancer therapy. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[21] B. Chang,et al. Hydrogen bonding between sugar and protein is responsible for inhibition of dehydration-induced protein unfolding. , 1999, Archives of biochemistry and biophysics.
[22] S. Frokjaer,et al. Effects of additives on the stability of recombinant human factor XIII during freeze-drying and storage in the dried solid. , 1998, Archives of biochemistry and biophysics.